Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8904 |
High Similarity |
NPD2935 |
Discontinued |
0.8716 |
High Similarity |
NPD2346 |
Discontinued |
0.8701 |
High Similarity |
NPD3226 |
Approved |
0.8599 |
High Similarity |
NPD7819 |
Suspended |
0.8571 |
High Similarity |
NPD6232 |
Discontinued |
0.8442 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8442 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8442 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8424 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8421 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8415 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8375 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8299 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8289 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8282 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8278 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8278 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8278 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8278 |
Intermediate Similarity |
NPD5404 |
Approved |
0.825 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8228 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.821 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8205 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8158 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8137 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8117 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8092 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8092 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.8086 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8065 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD7003 |
Approved |
0.8059 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8057 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8046 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8024 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7965 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7965 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7963 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7959 |
Intermediate Similarity |
NPD1203 |
Approved |
0.795 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7949 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7935 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7922 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7911 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7892 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7891 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7875 |
Intermediate Similarity |
NPD920 |
Approved |
0.7871 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7866 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7838 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7829 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7815 |
Intermediate Similarity |
NPD411 |
Approved |
0.7812 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7805 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.78 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7778 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7771 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7755 |
Intermediate Similarity |
NPD9717 |
Approved |
0.775 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7719 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7712 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7711 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7702 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7701 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7688 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7687 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7671 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7667 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7658 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7654 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7643 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7625 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7597 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7588 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6099 |
Approved |
0.758 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7562 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7554 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7545 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7531 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7531 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7515 |
Intermediate Similarity |
NPD919 |
Approved |
0.75 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7468 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7468 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7455 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7433 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7433 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7433 |
Intermediate Similarity |
NPD7697 |
Approved |
0.743 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7429 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7425 |
Intermediate Similarity |
NPD37 |
Approved |
0.7425 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7417 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7414 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7396 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7396 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7382 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7382 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7365 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7333 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7333 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7325 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD17 |
Approved |
0.7312 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7289 |
Intermediate Similarity |
NPD2370 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7283 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.724
|
Intermediate Similarity |
NPD8151 |
Discontinued |